Cambria Investment Management, L.P.
Position in LLY — ELI LILLY & Co
CIK 1529389
Manhattan Beach, CA
Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,990,828
+$3,040,916 QoQ
Shares Held
4,161
+96.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,722
of 4,621 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cambria Investment Management, L.P. holds $25,681,902 across 10 Drug Manufacturers - General names. LLY ranks #2 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
429,762 | $10,348,668 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
4,161 | $4,990,828 | |
| 3 | ABBV |
AbbVie Inc.
|
11,859 | $2,984,198 | |
| 4 | JNJ |
Johnson & Johnson
|
7,734 | $1,964,203 | |
| 5 | AMGN |
Amgen Inc
|
5,093 | $1,844,277 | |
| 6 | MRK |
Merck & Co., Inc.
|
11,069 | $1,422,366 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,599 | $960,057 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
9,573 | $551,596 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,990,828 | 4,161 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,949,912 | 2,120 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,439,523 | 2,270 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,089,564 | 1,428 | Shares | Other | 2025-12-01 | |
| 2025-06-30 | $313,371 | 402 | Shares | Other | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||